156 related articles for article (PubMed ID: 29980101)
1. Forced degradation of l-(+)-bornesitol, a bioactive marker of Hancornia speciosa: Development and validation of stability indicating UHPLC-MS method and effect of degraded products on ACE inhibition.
Gomes JHS; da Silva GC; Côrtes SF; de Pádua RM; Braga FC
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1093-1094():31-38. PubMed ID: 29980101
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of an HPLC-DAD method for quantification of bornesitol in extracts from Hancornia speciosa leaves after derivatization with p-toluenesulfonyl chloride.
Pereira AB; Veríssimo TM; Oliveira MA; Araujo IA; Alves RJ; Braga FC
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():133-7. PubMed ID: 22333437
[TBL] [Abstract][Full Text] [Related]
3. Determination of l-(+)-bornesitol, the hypotensive constituent of Hancornia speciosa, in rat plasma by LC-MS/MS and its application on a pharmacokinetic study.
Moreira LN; Feltrin C; Gonçalves JE; de Castro WV; Simões CMO; de Pádua RM; Cortes SF; Braga FC
Biomed Pharmacother; 2020 Dec; 132():110900. PubMed ID: 33113433
[TBL] [Abstract][Full Text] [Related]
4. Definition of chemical markers for Hancornia speciosa Gomes by chemometric analysis based on the chemical composition of extracts, their vasorelaxant effect and α-glucosidase inhibition.
Pereira ABD; Gomes JHS; Pereira AC; Pádua RM; Côrtes SF; Sena MM; Braga FC
J Ethnopharmacol; 2022 Dec; 299():115692. PubMed ID: 36084818
[TBL] [Abstract][Full Text] [Related]
5. The Cyclitol L-(+)-Bornesitol as an Active Marker for the Cardiovascular Activity of the Brazilian Medicinal Plant Hancornia speciosa.
Moreira LN; Silva GC; Câmara DV; Pádua RM; Lemos VS; Braga FC; Cortes SF
Biol Pharm Bull; 2019; 42(12):2076-2082. PubMed ID: 31787722
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB inhibitory activity of cyclitols isolated from Hancornia speciosa.
Endringer DC; Pezzuto JM; Braga FC
Phytomedicine; 2009 Nov; 16(11):1064-9. PubMed ID: 19423310
[TBL] [Abstract][Full Text] [Related]
7. Hancornia speciosa Gomes induces hypotensive effect through inhibition of ACE and increase on NO.
Silva GC; Braga FC; Lima MP; Pesquero JL; Lemos VS; Cortes SF
J Ethnopharmacol; 2011 Sep; 137(1):709-13. PubMed ID: 21756990
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Wound Healing Properties of Hancornia speciosa Leaves.
Geller FC; Teixeira MR; Pereira AB; Dourado LP; Souza DG; Braga FC; Simões CM
Phytother Res; 2015 Dec; 29(12):1887-93. PubMed ID: 26344935
[TBL] [Abstract][Full Text] [Related]
9. Structural characterization of a proanthocyanidin-rich fraction from Hancornia speciosa leaves and its effect on the release of pro-inflammatory cytokines and oxidative stress in THP-1 cells.
Carneiro Junior WO; Guimarães MLR; Freitas KM; Pereira RS; Pádua RM; Campana PRV; Braga FC
J Ethnopharmacol; 2024 Jun; 333():118471. PubMed ID: 38901680
[TBL] [Abstract][Full Text] [Related]
10. ESI-MSn and LC-ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC-UV method.
Bansal G; Singh R; Saini B; Bansal Y
J Pharm Biomed Anal; 2013 Jan; 72():186-97. PubMed ID: 22999302
[TBL] [Abstract][Full Text] [Related]
11. Forced degradation of nepafenac: Development and validation of stability indicating UHPLC method.
Runje M; Babić S; Meštrović E; Nekola I; Dujmić-Vučinić Ž; Vojčić N
J Pharm Biomed Anal; 2016 May; 123():42-52. PubMed ID: 26871279
[TBL] [Abstract][Full Text] [Related]
12. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
[TBL] [Abstract][Full Text] [Related]
13. Development of a fast liquid chromatography/mass spectrometry screening method for angiotensin-converting enzyme (ACE) inhibitors in complex natural mixtures like snake venom.
Siemerink M; Schebb NH; Liesener A; Perchuc AM; Schöni R; Wilmer M; Hayen H; Karst U; Vogel M
Rapid Commun Mass Spectrom; 2010 Mar; 24(5):687-97. PubMed ID: 20162537
[TBL] [Abstract][Full Text] [Related]
14. LC-MS/MS characterization of forced degradation products of zofenopril.
Ramesh T; Nageswara Rao P; Nageswara Rao R
J Pharm Biomed Anal; 2014 Jan; 88():609-16. PubMed ID: 24211724
[TBL] [Abstract][Full Text] [Related]
15. Screening of inhibitors of angiotensin-converting enzyme (ACE) employing high performance liquid chromatography-electrospray ionization triple quadrupole mass spectrometry (HPLC-ESI-QqQ-MS).
Musharraf SG; Bhatti MS; Choudhary MI; Rahman AU
Eur J Pharm Sci; 2017 Apr; 101():182-188. PubMed ID: 28189816
[TBL] [Abstract][Full Text] [Related]
16. Hancornia speciosa Gomes (Apocynaceae) as a potential anti-diabetic drug.
Pereira AC; Pereira AB; Moreira CC; Botion LM; Lemos VS; Braga FC; Cortes SF
J Ethnopharmacol; 2015 Feb; 161():30-5. PubMed ID: 25500300
[TBL] [Abstract][Full Text] [Related]
17. Stability-Indicating Reversed-Phase UHPLC Method Development and Characterization of Degradation Products of Almotriptan Maleate by LC-QTOF-MS/MS.
Saibaba B; Vishnuvardhan C; Johnsi Rani P; Satheesh Kumar N
J Chromatogr Sci; 2018 Jan; 56(1):6-17. PubMed ID: 28977362
[TBL] [Abstract][Full Text] [Related]
18. Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method.
Bhardwaj SP; Singh S
J Pharm Biomed Anal; 2008 Jan; 46(1):113-20. PubMed ID: 17964751
[TBL] [Abstract][Full Text] [Related]
19. Identification of Phenolic Compounds from Hancornia speciosa (Apocynaceae) Leaves by UHPLC Orbitrap-HRMS.
Bastos KX; Dias CN; Nascimento YM; da Silva MS; Langassner SM; Wessjohann LA; Tavares JF
Molecules; 2017 Jan; 22(1):. PubMed ID: 28098848
[TBL] [Abstract][Full Text] [Related]
20. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
